Document Detail


Risk of Cancer in Patients With Autoimmune Pancreatitis.
MedLine Citation:
PMID:  23318486     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES:Although simultaneous occurrences of autoimmune pancreatitis (AIP) and cancer are occasionally observed, it remains largely unknown whether cancer and AIP occur independently or these disorders are interrelated. The aim of this study was to examine the relationship between AIP and cancer.METHODS:We conducted a multicenter, retrospective cohort study. One hundred and eight patients who met the Asian diagnostic criteria for AIP were included in the study. We calculated the proportion, standardized incidence ratio (SIR), relative risk, and time course of cancer development in patients with AIP. We also analyzed the clinicopathological characteristics of AIP patients with cancer in comparison with those without cancer.RESULTS:Of the 108 AIP patients, 18 cancers were found in 15 patients (13.9%) during the median follow-up period of 3.3 years. The SIR of cancer was 2.7 (95% confidence interval (CI) 1.4-3.9), which was stratified into the first year (6.1 (95% CI 2.3-9.9)) and subsequent years (1.5 (95% CI 0.3-2.8)) after AIP diagnosis. Relative risk of cancer among AIP patients at the time of AIP diagnosis was 4.9 (95% CI 1.7-14.9). In six of eight patients whose cancer lesions could be assessed before corticosteroid therapy for AIP, abundant IgG4-positive plasma cell infiltration was observed in the cancer stroma. These six patients experienced no AIP relapse after successful cancer treatment.CONCLUSIONS:Patients with AIP are at high risk of having various cancers. The highest risk for cancer in the first year after AIP diagnosis and absence of AIP relapse after successful treatment of the coexisting cancers suggest that AIP may develop as a paraneoplastic syndrome in some patients.Am J Gastroenterol advance online publication, 15 January 2013; doi:10.1038/ajg.2012.465.
Authors:
Masahiro Shiokawa; Yuzo Kodama; Kenichi Yoshimura; Chiharu Kawanami; Jun Mimura; Yukitaka Yamashita; Masanori Asada; Masataka Kikuyama; Yoshihiro Okabe; Tetsuro Inokuma; Masaya Ohana; Hiroyuki Kokuryu; Kazuo Takeda; Yoshihisa Tsuji; Ryuki Minami; Yojiro Sakuma; Katsutoshi Kuriyama; Yuji Ota; Wataru Tanabe; Takahisa Maruno; Akira Kurita; Yugo Sawai; Norimitsu Uza; Tomohiro Watanabe; Hironori Haga; Tsutomu Chiba
Related Documents :
22272666 - Colorectal cancer screening of high-risk populations: a national survey of physicians.
12390356 - Swelling, numbness, pain, and their relationship to arm function among breast cancer su...
22971126 - Hospital factors and patient characteristics in the treatment of colorectal cancer: a p...
24023876 - White blood cell count measured prior to cancer development is associated with future r...
21297996 - Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-bas...
3812846 - A comparison of estrogen and progesterone receptors in black and white breast cancer pa...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-15
Journal Detail:
Title:  The American journal of gastroenterology     Volume:  -     ISSN:  1572-0241     ISO Abbreviation:  Am. J. Gastroenterol.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0421030     Medline TA:  Am J Gastroenterol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prediction of Barrett's esophagus among men.
Next Document:  Bedside Estimation of Nonaerated Lung Tissue Using Blood Gas Analysis.